Adaptive Biotechnologies (ADPT) Insider Trading & Ownership $5.66 +0.97 (+20.68%) (As of 09:20 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Adaptive Biotechnologies (NASDAQ:ADPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$429,325.41 Get ADPT Insider Trade Alerts Want to know when executives and insiders are buying or selling Adaptive Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADPT Insider Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Adaptive Biotechnologies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/18/2024Kyle PiskelCFOSell248$4.98$1,235.04 3/5/2024Chad M RobinsCEOSell48,673$3.43$166,948.39 3/5/2024Julie RubinsteinPresidentSell39,070$3.47$135,572.90 3/5/2024Kyle PiskelInsiderSell7,727$3.43$26,503.61 3/5/2024Stacy L TaylorSVPSell13,381$3.43$45,896.83 3/5/2024Tycho PetersonCFOSell15,456$3.44$53,168.64 (Data available from 1/1/2013 forward) ADPT Insider Trading Activity - Frequently Asked Questions Who is on Adaptive Biotechnologies's Insider Roster? The list of insiders at Adaptive Biotechnologies includes Chad M Cohen, Chad M Robins, Julie Rubinstein, Kyle Piskel, Lance Baldo, Michelle Renee Griffin, Nitin Sood, R Mark Adams, Stacy L Taylor, and Tycho Peterson. Learn more on insiders at ADPT. What percentage of Adaptive Biotechnologies stock is owned by insiders? 6.20% of Adaptive Biotechnologies stock is owned by insiders. Learn more on ADPT's insider holdings. Which Adaptive Biotechnologies insiders have been selling company stock? The following insiders have sold ADPT shares in the last 24 months: Chad M Robins ($166,948.39), Julie Rubinstein ($329,837.66), Kyle Piskel ($59,051.85), Michelle Renee Griffin ($19,875.09), Nitin Sood ($38,320.56), R Mark Adams ($71,355.53), Stacy L Taylor ($92,954.70), and Tycho Peterson ($2,020,931.18). How much insider selling is happening at Adaptive Biotechnologies? Insiders have sold a total of 415,797 Adaptive Biotechnologies shares in the last 24 months for a total of $2,799,274.96 sold. Adaptive Biotechnologies Key ExecutivesMr. Chad M. Robins M.B.A. (Age 49)Co-Founder, CEO & Chairman Compensation: $1MMs. Julie Rubinstein (Age 52)President & COO Compensation: $721.04kDr. Harlan S. Robins Ph.D. (Age 51)Co-Founder & Chief Scientific Officer Compensation: $711.09kDr. Sharon Benzeno Ph.D. (Age 50)Chief Commercial Officer of Immune Medicine Compensation: $630.72kMr. Christopher Carlson Ph.D.FounderMr. Kyle Piskel (Age 40)VP, CFO & Principal Accounting Officer Compensation: $375.9k1 recent tradesKarina CalzadillaVice President of Investor RelationsMs. Stacy L. Taylor (Age 64)Senior VP, General Counsel & Corporate Secretary Mr. Francis T. Lo (Age 43)Chief People Officer Ms. Susan Bobulsky (Age 43)Chief Commercial Officer of MRD More Insider Trading Tools from MarketBeat Related Companies Kymera Therapeutics Insider Trading SpringWorks Therapeutics Insider Trading Vericel Insider Trading Iovance Biotherapeutics Insider Trading Twist Bioscience Insider Trading CG Oncology Insider Trading Beam Therapeutics Insider Trading Apogee Therapeutics Insider Trading Tarsus Pharmaceuticals Insider Trading Recursion Pharmaceuticals Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ADPT) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
